SCHEMBL26746501

SCHEMBL26746501

CNC(=O)CSCC(=O)NCCN1C(=O)C[C@@H](OC)C1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ FOLH1 Q04609 1/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ POLB P06746 1/20 0.30
▸ HDAC3 O15379 1/20 0.30
▸ HDAC4 P56524 1/20 0.30
▸ HDAC1 Q13547 1/20 0.30
▸ HDAC7 Q8WUI4 1/20 0.30
▸ HDAC2 Q92769 1/20 0.30
▸ HDAC10 Q969S8 1/20 0.30
▸ HDAC11 Q96DB2 1/20 0.30
▸ HDAC8 Q9BY41 1/20 0.30
▸ HDAC6 Q9UBN7 1/20 0.30
▸ HDAC9 Q9UKV0 1/20 0.30
▸ HDAC5 Q9UQL6 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26746510 1.00 HPGD (0.32) HPGDHTTSMN1; SMN2ALDH1A1NPSR1
SCHEMBL21383821 0.91 FABP3 (0.34) HPGDHTTSMN1; SMN2ALDH1A1NPSR1
SCHEMBL21389301 0.91 FABP3 (0.34) HPGDHTTSMN1; SMN2ALDH1A1NPSR1
SCHEMBL24796018 0.91 MAPT (0.33) HPGDHTTSMN1; SMN2ALDH1A1NPSR1
SCHEMBL26634663 0.91 FABP3 (0.34) HPGDHTTSMN1; SMN2ALDH1A1NPSR1
SCHEMBL21389368 0.85 CYP1A2 (0.36) HPGDSMN1; SMN2ALDH1A1NPSR1KMT2A
SCHEMBL24796413 0.85 HPGD (0.40) HPGDSMN1; SMN2ALDH1A1NPSR1KMT2A
SCHEMBL26746253 0.84 KDM4E (0.33) HTTALDH1A1FOLH1KMT2AHDAC3
SCHEMBL26746697 0.84 KMT2A (0.32) HTTSMN1; SMN2ALDH1A1FOLH1KMT2A
SCHEMBL26746691 0.84 KMT2A (0.32) HTTSMN1; SMN2ALDH1A1FOLH1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR HPGD 2145/4885HTT 722/4885SMN1; SMN2 2080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback